LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | GW843682X | 3.33 | uM | LJP6 | 0.2469 | 0.0262 | -0.0207 | 0.0452 |
| MDA-MB-231 | HG-5-113-01 | 3.33 | uM | LJP5 | 0.3287 | 0.0228 | 0.0904 | 0.0376 |
| MDA-MB-231 | HG-5-88-01 | 3.33 | uM | LJP6 | 0.7952 | 0.0821 | 0.7246 | 0.1080 |
| MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 1.0092 | 0.0289 | 1.0117 | 0.0390 |
| MDA-MB-231 | JNK-9L | 3.33 | uM | LJP6 | 0.2053 | 0.0274 | -0.0770 | 0.0474 |
| MDA-MB-231 | JW-7-24-1 | 3.33 | uM | LJP6 | 0.6043 | 0.0461 | 0.4644 | 0.0610 |
| MDA-MB-231 | Lapatinib | 3.33 | uM | LJP6 | 0.9437 | 0.0126 | 0.9235 | 0.0174 |
| MDA-MB-231 | LDN-193189 | 3.33 | uM | LJP5 | 0.2979 | 0.1230 | 0.0474 | 0.1732 |
| MDA-MB-231 | Linifanib | 3.33 | uM | LJP6 | 1.0488 | 0.0358 | 1.0655 | 0.0477 |
| MDA-MB-231 | Linsitinib | 3.33 | uM | LJP5 | 0.8575 | 0.0470 | 0.8074 | 0.0626 |
| MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP5 | 0.1352 | 0.0473 | -0.1724 | 0.0751 |
| MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP6 | 0.1265 | 0.0418 | -0.1841 | 0.0680 |
| MDA-MB-231 | MK2206 | 3.33 | uM | LJP6 | 0.7737 | 0.0214 | 0.6937 | 0.0280 |
| MDA-MB-231 | Neratinib | 3.33 | uM | LJP5 | 0.5075 | 0.1169 | 0.3321 | 0.1610 |
| MDA-MB-231 | Nilotinib | 3.33 | uM | LJP5 | 0.8424 | 0.0803 | 0.7884 | 0.1061 |
| MDA-MB-231 | Nintedanib | 3.33 | uM | LJP6 | 0.8462 | 0.0664 | 0.7932 | 0.0874 |
| MDA-MB-231 | NU7441 | 3.33 | uM | LJP5 | 0.6382 | 0.0547 | 0.5102 | 0.0732 |
| MDA-MB-231 | Dactolisib | 3.33 | uM | LJP5 | 0.3882 | 0.0307 | 0.1707 | 0.0492 |
| MDA-MB-231 | NVP-TAE684 | 3.33 | uM | LJP6 | 0.3277 | 0.0398 | 0.0886 | 0.0615 |
| MDA-MB-231 | Palbociclib | 3.33 | uM | LJP6 | 0.4661 | 0.0090 | 0.2770 | 0.0129 |
| MDA-MB-231 | PD0325901 | 3.33 | uM | LJP5 | 0.2657 | 0.0200 | 0.0052 | 0.0339 |
| MDA-MB-231 | PD0325901 | 3.33 | uM | LJP6 | 0.2216 | 0.0294 | -0.0549 | 0.0489 |
| MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 1.0350 | 0.0063 | 1.0473 | 0.0080 |
| MDA-MB-231 | PD184352 | 3.33 | uM | LJP5 | 0.5875 | 0.0341 | 0.4422 | 0.0409 |
| MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 0.4529 | 0.0631 | 0.2583 | 0.0894 |